Khan, K. 2025. Pioglitazone for Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes: A Meta-Analysis. International Journal of Medical and Biomedical Studies. 9, 1 (Feb. 2025), 259–264. DOI:https://doi.org/10.32553/ijmbs.v9i1.3091.